Cancer-associated thrombosis (CAT) is a leading cause of death in cancer patients
receiving outpatient chemotherapy. The latest guidelines emphasize stratifying the patients …

Cancer-associated thrombosis (CAT) is a major cause of both morbidity and mortality in
cancer patients. Platelet count has been investigated as a predictor of CAT in various …

Simple Summary Cancer patients are at greater risk of developing venous
thromboembolism compared to the general population, which can lead to a decreased …

Patients with hematologic malignancy have an increased risk of venous thromboembolism
(VTE) compared to the general population. This risk is highest during the first months after …

Background Venous thromboembolism (VTE) is a well-documented complication of both
solid and hematologic malignancies, but there are fewer data on allogeneic hematopoietic …

Prevalence of and Risk Factors for Venous Thromboembolism in Patients With Lymphoma: A
Meta-Analysis Page 1 JANUARY 2024, VOL. 51, NO. 1 ONCOLOGY NURSING FORUM 59 …

Cancer patients have a high risk of developing venous thromboembolism and arterial
thrombosis, along with an increased risk of anticoagulant-related bleeding with primary and …

Background: A majority of patients included in risk assessment models (RAMs) developed to
predict venous thromboembolic events (VTE) in lymphoma were non-Hodgkin lymphoma …

我国肿瘤及其并发症的诊治水平虽然已取得了很大的提高, 但肿瘤患者导管相关血栓形成的发生
率, 致残率及致死率仍然很高. 因此, 本研究梳理了近年来有关导管相关性血栓形成的中外文文献 …

Objetivo: Describir la influencia de factores de riesgo y biomarcadores de la enfermedad
tromboembólica venosa asociada a hemopatías malignas y su aplicación en el diseño de …